Loading
Transcenta Holding Ltd. - B Stock: price and insider trades · Hong Kong
2 insiders bought €58k of shares over the last 90 days, the latest by Cheng Genhong, filed 06 Oct 2026.
Transcenta Holding Ltd. - B: what insiders have been doing
This page follows insider dealings at Transcenta Holding Ltd. - B as filed with HKEX, a company from the Health Care sector. Over the twelve months to 23 October 2026, 30 filings were filed, from 8 insiders.
The record shows 13 purchases on the open market worth €86k, made by 3 insiders, against 2 sales by 2 insiders. The totals exclude 5 filings filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Those buying include 3 senior executives. The largest single trade was a purchase of €35k by Qian Xueming, published on 11 September 2026, equal to 0.11% of the market capitalisation.
The clock since the last published purchase (6 October 2026) now reads 18 days. Filings reach the HKEX feed a median of 6 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done.
Compared with its exchange (1,315 companies, median 4 filings), a count of 30 filings is above the norm. Over the whole record (from 2021), the tally stands at 246 purchases and 8 sales.
Other companies in the same sector with recent insider buying flagged by our signals: EssilorLuxottica and Dynavox Group AB. Source: insider filings from HKEX. Past trades are no guide to future returns.
Insider Decl.
276
Thresholds
n/a
Buy Volume
€2M
246 ops. · all time
Sell Volume
n/a
8 ops. · all time
Who traded when
BuySaleQian Xueming40 buys
Cheng Genhong2 buys1 sale
Xu Hansen1 buy
Zhang Zhihua1 sale
Since the insiders bought
- -45.5%Entry HK$1.10 · Close 22 Oct 2026 HK$0.60
- -45.5%Entry HK$1.10 · Close 22 Oct 2026 HK$0.60
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 25,436 of 26,289 companies
12.6
score / 100
Value3
Quality22
FCF yld-55%
Earn yld-79%
EV/EBITDA·
ROE-27%
Gross mgn23%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
HK$0.63
Analyst consensus
Income statement
RevenueHK$7.4M
Gross profitHK$1.7M23% margin
EBITDA-HK$148.8M-2002% margin
Net income-HK$203.7M-2740.1% margin
Valuation
P/Book0.4x
Beta-0.45
Balance sheet & cash
Market capHK$266.8M
Total debtHK$126.3M
Free Cash Flow-HK$143M
Debt / Equity25%
Profitability & ownership
ROE-26.8%
ROA-9.6%
% insiders12.0%
% institutions27.9%
Last declaration on 6 October 2026
Declarations276 total
30,000 sharesShareXHKGHKEX:DA20261005E00266
30,000 sharesShareXHKGHKEX:DA20261005E00267
Canonical exit: 29 Dec 2026 (T+90)
70,000 shares@ HK$0.89640.022% mcap0.4% of flowShareXHKGHKEX:DA20260918E00096
Canonical exit: 15 Dec 2026 (T+90)
100,000 shares@ HK$0.85520.030% mcap0.6% of flowShareXHKGHKEX:DA20260918E00097
Canonical exit: 16 Dec 2026 (T+90)
310,000 shares@ HK$1.02210.11% mcap2.1% of flowShareXHKGHKEX:DA20260911E00118
Canonical exit: 7 Dec 2026 (T+90)
20,000 shares@ HK$0.9250.0064% mcap0.1% of flowShareXHKGHKEX:DA20260911E00120
Canonical exit: 9 Dec 2026 (T+90)
40,000 shares@ HK$0.9950.014% mcap0.3% of flowShareXHKGHKEX:DA20260911E00119
Canonical exit: 8 Dec 2026 (T+90)
30,000 sharesShareXHKGHKEX:DA20260902E00471
Canonical exit: 26 Nov 2026 (T+90)
30,000 sharesShareXHKGHKEX:DA20260706E00776
Canonical exit: 28 Sept 2026 (T+90)
20,000 sharesShareXHKGHKEX:DA20260701E00202
10,000 sharesShareXHKGHKEX:DA20260701E00201
10,000 sharesShareXHKGHKEX:DA20260626E00251
10,000 sharesShareXHKGHKEX:DA20260626E00240
30,000 shares@ HK$2.14330.012% mcap10.8% of flowShareXHKGHKEX:DA20260507E00121
Canonical exit: 3 Aug 2026 (T+90)
10,000 shares100.0% of flowShareXHKGHKEX:DA20260430E00477
461,640 shares75.5% of flowShareXHKGHKEX:DA20260430E00576
150,000 shares24.5% of flowShareXHKGHKEX:DA20260430E00575
10,000 shares50.0% of flowShareXHKGHKEX:DA20260430E00476
8,020 shares1.3% of flowShareXHKGHKEX:DA20260430E00573
10,000 shares50.0% of flowShareXHKGHKEX:DA20260430E00518
10,000 shares50.0% of flowShareXHKGHKEX:DA20260430E00517
10,000 shares50.0% of flowShareXHKGHKEX:DA20260430E00102
10,000 shares50.0% of flowShareXHKGHKEX:DA20260430E00101
10,000 shares50.0% of flowShareXHKGHKEX:DA20260417E00676
10,000 shares50.0% of flowShareXHKGHKEX:DA20260417E00675
25 of 276 declarations
About Transcenta Holding Ltd. - B
Transcenta Holding Ltd. is a company focused on the health and pharmaceutical sector, dedicated to developing innovative biological therapies. It is listed on the Hong Kong Stock Exchange under the symbol XHKG.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
